← Back to Search

Artificial Intelligence Care Coach for Dementia Caregivers

N/A

Recruiting

Led By Cameron Gettel

Research Sponsored by Yale University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Age ≥65 years with a diagnosis of dementia within the electronic health record OR new cognitive impairment identified during an ED visit

Discharge after an ED visit

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 30

Awards & highlights

Study Summary

This trial aims to create AI tools to help caregivers of older adults with cognitive issues during their emergency department care transitions.

Who is the study for?

This trial is for caregivers of older adults aged 65 or above with dementia or new cognitive impairment identified during an ED visit. Participants must speak English or Spanish, be discharged after an ED visit, and have a smart device with internet to use the NeuViCare AI services. Those showing signs of delirium are not eligible.Check my eligibility

What is being tested?

The study is testing the NeuViCare application, which uses artificial intelligence to help manage care transitions after older adults with cognitive impairments are discharged from the emergency department.See study design

What are the potential side effects?

Since this trial involves using an AI-based application rather than medication, traditional side effects like those seen in drug trials may not apply. However, users might experience stress or frustration if they encounter technical difficulties.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 65 or older and have been diagnosed with dementia or noticed new memory problems.

Select...

I was recently discharged from the emergency department.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 30

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 30

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 30 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Acceptability of Intervention Measure

Feasibility of Intervention Measure

Intervention Appropriateness Measure

+1 more

Secondary outcome measures

Dementia Knowledge Assessment Scale

Emergency Department revisits

General Self-Efficacy Scale

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Intervention (NeuViCare AI)Experimental Treatment1 Intervention

An anticipated 55 participants will be part of the Intervention arm participants and will engage with NeuViCare AI, including all variations of its 5 components described further below.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

West Health InstituteUNKNOWN

National Institute on Aging (NIA)NIH

1,671 Previous Clinical Trials

28,017,008 Total Patients Enrolled

266 Trials studying Dementia

23,625,305 Patients Enrolled for Dementia

Emergency Medicine FoundationOTHER

17 Previous Clinical Trials

2,330 Total Patients Enrolled

Media Library

Intervention (NeuViCare AI) Clinical Trial Eligibility Overview. Trial Name: NCT05352399 — N/A

Dementia Research Study Groups: Intervention (NeuViCare AI)

Dementia Clinical Trial 2023: Intervention (NeuViCare AI) Highlights & Side Effects. Trial Name: NCT05352399 — N/A

Intervention (NeuViCare AI) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05352399 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there available slots for new participants in this research?

"Current records on clinicaltrials.gov demonstrate that this medical trial is accepting participants; the original post was made in March 20,2023 and an update occurred as recently as May 4th, 2023."

Answered by AI

How many participants are actively engaging in this research?

"Affirmative. The current status of the trial is visible on clinicaltrials.gov, which states that it was initially announced on March 20th 2023 and recently updated on May 4th 2023. This project requires 55 volunteers from a single medical facility to participate in order for it to be complete."

Answered by AI

What objectives are clinicians hoping to accomplish through this research?

"The principal aim of this clinical trial, monitored over a period of 30 days, is to measure the appropriateness of intervention. Secondary objectives include assessing hospitalizations through electronic health records and surveys as well as revisits to emergency departments for further evaluation. Additionally, respondents will complete the Dementia Knowledge Assessment Scale survey which takes 10-15 minutes and consists of true/false questions intended to assess their knowledge across four domains: causes & characteristics; communication & behaviour; care considerations; risks & health promotion - with scores ranging from 0-21."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Artificial Intelligence + Care Coach Intervention

2023. "Artificial Intelligence + Care Coach Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05352399.

All > Dementia